These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12192774)

  • 61. The use of instrumental variables: an alternative to traditional modeling?
    Neyt M; Van Brabandt H; De Laet C
    Value Health; 2011 Jan; 14(1):1-2. PubMed ID: 21211480
    [No Abstract]   [Full Text] [Related]  

  • 62. Stents may replace some angioplasties.
    Alexander W
    OR Manager; 1994 Dec; 10(12):13-5. PubMed ID: 10139071
    [No Abstract]   [Full Text] [Related]  

  • 63. Cardiovascular device technology and health care cost.
    Dean LS
    Arch Intern Med; 2011 Oct; 171(18):1689; author's reply 1689. PubMed ID: 21987207
    [No Abstract]   [Full Text] [Related]  

  • 64. Antithrombotic therapy after coronary-artery stenting.
    Wohl VR; Hecht E; Shaughnessy K
    N Engl J Med; 1999 Apr; 340(17):1366; author reply 1367-8. PubMed ID: 10223875
    [No Abstract]   [Full Text] [Related]  

  • 65. President's page: managing managed care--a mission impossible?
    Chernoff R
    J Am Diet Assoc; 1996 Jul; 96(7):715. PubMed ID: 8675918
    [No Abstract]   [Full Text] [Related]  

  • 66. Static and dynamic efficiency of irreversible health care investments under alternative payment rules.
    Levaggi R; Moretto M; Pertile P
    J Health Econ; 2012 Jan; 31(1):169-79. PubMed ID: 22019114
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diamond mining. Interview by Charlene Marietti.
    Diamond C
    Healthc Inform; 2000 Jan; 17(1):47-8, 50, 52. PubMed ID: 10977623
    [No Abstract]   [Full Text] [Related]  

  • 68. Cost Effective Diagnosis and Treatment of Atherosclerosis. Proceedings of the Western Canada Specialists' Meeting. Whistler, British Columbia, Canada, December 9-10, 1994.
    Can J Cardiol; 1995 May; 11 Suppl C():3C-42C. PubMed ID: 7750047
    [No Abstract]   [Full Text] [Related]  

  • 69. 34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective?
    Mark DB; Shaw LJ; Lauer MS; O'Malley PG; Heidenreich P
    J Am Coll Cardiol; 2003 Jun; 41(11):1906-17. PubMed ID: 12798557
    [No Abstract]   [Full Text] [Related]  

  • 70. Digital technology to support self-management in patients with coronary disease.
    Landmesser U; MacRae CA
    Lancet Digit Health; 2019 Jun; 1(2):e50-e51. PubMed ID: 33323228
    [No Abstract]   [Full Text] [Related]  

  • 71. Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues.
    Hodgson JM; Bottner RK; Klein LW; Walpole HT; Cohen DJ; Cutlip DE; Fenninger RB; Firth BG; Greenberg D; Kalisky I; Meskan T; Powell W; Stone GW; Zito JP; Clark MA
    Catheter Cardiovasc Interv; 2004 May; 62(1):1-17. PubMed ID: 15103593
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Managing technological explosion in the medical management of coronary artery disease, Part II. DES economic modeling: budgeting strategies for drug-eluting stent technology.
    Chumer K; DeCerce J; Vaul J
    J Cardiovasc Manag; 2002; 13(4):16-20. PubMed ID: 12192774
    [No Abstract]   [Full Text] [Related]  

  • 73. Managing technological explosion in the medical management of coronary artery disease. Cardiovascular administrators are key internal consultants in planning for drug-eluting stent technology.
    DeCerce J; Chumer K
    J Cardiovasc Manag; 2002; 13(3):13-6. PubMed ID: 12048868
    [No Abstract]   [Full Text] [Related]  

  • 74. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lack of efficacy and cost-effectiveness of drug-eluting stents.
    Lyratzopoulos G
    Eur Heart J; 2006 Dec; 27(24):3075-6; author reply 3076. PubMed ID: 17127710
    [No Abstract]   [Full Text] [Related]  

  • 76. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.